Virtu KCG Holdings’s DMK Pharmaceuticals DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$200K Buy
550
+279
+103% +$83.5K 0.01% 2165
2017
Q1
$80K Buy
+271
New +$68.4K ﹤0.01% 2744
2016
Q4
– Sell
-1,310
Closed -$315K – 3897
2016
Q3
$315K Buy
1,310
+960
+274% +$200K 0.01% 1875
2016
Q2
$69K Buy
+350
New +$161K ﹤0.01% 2617
2015
Q4
– Sell
-146
Closed -$40K – 4056
2015
Q3
$40K Buy
+146
New +$40.7K ﹤0.01% 3056
2015
Q1
– Sell
-228
Closed -$99K – 4029
2014
Q4
$99K Buy
+228
New +$72.4K ﹤0.01% 3239

Other funds holding DMK

Virtu KCG Holdings's DMK Position: Q2 2017 in Review

Virtu KCG Holdings increased its DMK Pharmaceuticals (DMK) stake by 103% in Q2 2017, buying an estimated $83.5K and bringing the position to 550 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #2165.

Virtu KCG Holdings first reported a position in DMK in Q4 2014 and has held it in 6 quarters since. The position peaked at $315K in Q3 2016. 44 funds tracked by Wall St. Rank hold DMK as of Q2 2017.

  • Virtu KCG Holdings held 550 shares of DMK Pharmaceuticals worth $200K as of Q2 2017.
  • Virtu KCG Holdings bought 279 DMK Pharmaceuticals shares in Q2 2017, an estimated $83.5K.
  • DMK Pharmaceuticals made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2165 holding.
  • Virtu KCG Holdings first reported a position in DMK Pharmaceuticals in Q4 2014 and has held it in 6 quarters since.
  • Virtu KCG Holdings's DMK Pharmaceuticals position peaked at $315K in Q3 2016.
  • 44 funds tracked by Wall St. Rank held DMK Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.